内脏静脉血栓形成中的JAK2V617F突变与骨髓增殖性疾病 - Suppr | 超能文献

JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis.

作者信息

Qi X, Hu F, Yang Z, Han G, Fan D

出版信息

Aliment Pharmacol Ther. 2011 Feb;33(4):495-6; author reply 496-7. doi: 10.1111/j.1365-2036.2010.04533.x.

DOI:10.1111/j.1365-2036.2010.04533.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis.内脏静脉血栓形成中的JAK2V617F突变与骨髓增殖性疾病

Aliment Pharmacol Ther. 2011 Feb;33(4):495-6; author reply 496-7. doi: 10.1111/j.1365-2036.2010.04533.x.

2

JAK2V617F mutation is ubiquitously present in splanchnic vein thrombosis accompanying myeloproliferative syndromes.JAK2V617F突变普遍存在于伴有骨髓增殖性综合征的内脏静脉血栓形成中。

Aliment Pharmacol Ther. 2011 Jun;33(12):1382-3. doi: 10.1111/j.1365-2036.2011.04670.x.

3

Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.与内脏静脉血栓形成相关的JAK2 V617F突变的患病率：一项10年回顾性研究。

Thromb Haemost. 2009 Apr;101(4):787-9.

4

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.内脏静脉血栓形成且无明显骨髓增殖性肿瘤患者中JAK2外显子12突变缺失。

Am J Hematol. 2009 Feb;84(2):126-7. doi: 10.1002/ajh.21335.

5

JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.无明显骨髓增殖性疾病情况下非内脏静脉血栓形成中JAK2V617F的患病率和等位基因负荷。

Leukemia. 2007 Aug;21(8):1828-9. doi: 10.1038/sj.leu.2404710. Epub 2007 Apr 26.

6

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.慢性门-体-肠系膜静脉血栓形成中 JAK2 酪氨酸激酶激活突变的流行情况。

Aliment Pharmacol Ther. 2010 Jun;31(12):1330-6. doi: 10.1111/j.1365-2036.2010.04299.x. Epub 2010 Mar 13.

7

Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.无骨髓增殖性肿瘤的中国深静脉血栓形成患者中JAK2V617F突变缺失

Thromb Res. 2012 May;129(5):664-5. doi: 10.1016/j.thromres.2011.12.018. Epub 2011 Dec 22.

8

JAK2V617F mutation in patients with splanchnic vein thrombosis.JAK2V617F 突变与肠系膜静脉血栓形成。

Dig Dis Sci. 2010 Jun;55(6):1770-7. doi: 10.1007/s10620-009-0933-y. Epub 2009 Aug 19.

9

High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis.肝外门静脉血栓形成患者中JAK2 V617F突变的高患病率。

Hepatology. 2007 Mar;45(3):831-2; author reply 832-3. doi: 10.1002/hep.21601.

10

Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease.下腔静脉血栓形成及其与 JAK2V617F 突变和慢性骨髓增殖性疾病的关系。

Thromb Res. 2012 Jun;129(6):720-4. doi: 10.1016/j.thromres.2011.09.011. Epub 2011 Oct 7.